E.T.View Medical was acquired by Ambu A/S in September 2016.
E.T.View Medical has developed a portfolio of products that provide continuous visualization and ventilation of the airway during surgical procedures.
E.T.View presents a major advance in continuous visualization of the airways during thoracic surgical procedures. The VivaSight™ portfolio products (VivaSight-SL and VivaSight-DL) are fully integrated imaging/ventilation systems that allow continuous airway visualization and ventilation for accurate placement and constant airway control — without any modifications to the standard intubation procedure. VivaSight: The only platform that allows for continuous, real-time management of the airways in the OR, ER, and ICU.
VivaSight clearance and certification: FDA, CE (MDD 93/42/EEC), ISO 9001:2000, ISO 13485:2003
E.T.View has distribution agreements in North America, South America, Europe, Asia, and Africa.
Caution: Federal (US) law restricts this device to sale by or on the order of a licensed health care practitioner.
Stage: Public company (Tel Aviv Stock Exchange) until acquisition by Ambu
During lung isolation procedures, placement of a single-lumen tube (SLT) with a bronchial blocker or a double-lumen tube (DLT) requires the use of a bronchoscope to confirm — and reconfirm — the correct position within the trachea.
Bronchoscopes, susceptible to mechanical damage from handling during normal use (and subsequent expensive repair costs), do not provide continuous visualization and may even obscure the airway when used with an endotracheal tube (ET). Additionally, intraoperative ET displacement, bronchial blocker dislocation, or other adverse airway events may occur unexpectedly, requiring immediate intervention.
Minimally invasive treatment of heart valve disease
A more efficient ablation catheter to treat atrial fibrillation
Preventing the development of pressure sores
Novel treatment for vertebral compression fractures
Preventing catheter-associated urinary tract infections (CAUTIs)
Wireless, wearable vital sign monitoring system
Cryotherapy for superficial bladder cancer